Product image of Ipertrofan (Mepartricin) supplied by GNH India

Ipertrofan

Active Ingredient:
Mepartricin
Origin:
EU

Ipertrofan (Mepartricin)

Mepartricin, the active ingredient in Ipertrofan, is a macrolide antibiotic presented as an oral formulation for systemic use. Approved in the European Union, the product targets pathogens implicated in chronic prostatitis, urogenital infections and chronic pelvic pain syndrome, providing clinicians with a targeted antibacterial option.

GNH India supplies Ipertrofan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality manufacturing, regulatory compliance, and reliable logistics for global distribution.

Manufacturer / TM Owner

Spa – Società Prodotti Antibiotici S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ipertrofan (mepartricin) is used to treat bacterial infections of the urogenital tract and related chronic conditions.

  • Chronic prostatitis: reduces bacterial load and inflammation in the prostate.
  • Urogenital infections: eradicates susceptible bacteria causing urinary and genital infections.
  • Chronic pelvic pain syndrome: alleviates symptoms associated with a bacterial component of pelvic pain.

How It Works

  • Mepartricin binds to the 50S ribosomal subunit of susceptible bacteria, inhibiting peptide chain elongation and thereby blocking protein synthesis. This bacteriostatic action prevents bacterial growth and facilitates clearance by the host immune system.

Side Effects

Adverse reactions to Ipertrofan may vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools occurring during treatment.
  • Abdominal pain: discomfort or cramps in the abdomen.
  • Headache: mild to moderate head pain.
  • Dizziness: sensation of lightheadedness.
  • Taste disturbance: altered sense of taste.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction with rash, swelling, and breathing difficulty.
  • Hepatic enzyme elevation: significant increase in liver function tests.
  • Clostridioides difficile infection: severe colitis presenting with watery diarrhea.
  • Severe neutropenia: marked reduction in white blood cells increasing infection risk.
  • Cardiac arrhythmia: irregular heart rhythm in susceptible individuals.

Precautions & Warnings

Before prescribing Ipertrofan, clinicians should consider several safety aspects.

  • Renal impairment: assess kidney function and monitor if needed.
  • Hepatic impairment: use with caution and monitor liver enzymes.
  • Pregnancy: only if benefit outweighs potential risk; data are limited.
  • Breastfeeding: avoid unless clearly indicated by a physician.
  • Concomitant macrolides: avoid additive toxicity.
  • Store at ambient temperature: keep below 25°C, in original packaging, protected from moisture.

Avoid Interactions

Ipertrofan may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Other macrolide antibiotics: increased risk of toxicity.
  • Anticoagulants (e.g., warfarin): potential for enhanced bleeding.
  • Statins (e.g., simvastatin): heightened risk of myopathy.

Moderate Interactions (Monitor Closely)

  • Antacids containing aluminum or magnesium: may reduce absorption.
  • P‑glycoprotein substrates: possible altered plasma levels.
  • QT‑prolonging agents: monitor cardiac rhythm.

Frequently Asked Questions

Ipertrofan contains mepartricin, a macrolide antibiotic indicated for the treatment of chronic prostatitis, urogenital infections, and chronic pelvic pain syndrome where bacterial involvement is identified. It is prescribed by qualified healthcare professionals for adult patients with these conditions.

Mepartricin binds to the bacterial 50S ribosomal subunit, blocking peptide chain elongation and inhibiting protein synthesis. This bacteriostatic effect halts bacterial growth, allowing the immune system to clear the infection.

The dosage of Ipertrofan is determined by the prescribing physician based on the specific infection, severity, patient characteristics, and local guidelines. Patients should follow the exact regimen provided on the prescription label.

Safety data for mepartricin during pregnancy and lactation are limited. The drug should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Compared with other macrolides such as erythromycin, mepartricin offers a similar mechanism of inhibiting bacterial protein synthesis but may have a different spectrum of activity and safety profile. Choice of therapy depends on pathogen susceptibility, patient tolerance, and clinical guidelines.

Ipertrofan should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Ipertrofan is taken orally, usually as a tablet or capsule, with or without food as directed by the prescriber. The exact administration instructions, including timing and any required fluid intake, are provided on the prescription label.

Serious adverse reactions may include severe allergic responses such as anaphylaxis, significant liver enzyme elevations, and rare cases of Clostridioides difficile‑associated colitis. Patients should seek immediate medical attention if they experience symptoms such as rash, jaundice, persistent diarrhea, or difficulty breathing.

Ipertrofan is contraindicated in patients with a known hypersensitivity to mepartricin or other macrolide antibiotics. Caution is also advised for individuals with severe hepatic impairment, and it should be avoided in pregnant or nursing women unless clearly indicated by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mepartricin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT